AACR Annual Meeting, April 16-20, 2016
Schedule of Winship Poster and Speaker Sessions
Sunday, April 17, 2016
Location
Section 24
Section 34
Time
1:00pm-5:00pm
1:00pm-5:00pm
Presentation
Room 291, Morial Convention Center
2:45pm-3:10pm
Presentation # Poster # Author(s)
515
2 Xu Wang/Nabil Saba
780
9 Daniel Brat
Sagar Lonial
Title (Click on presentation title for detail)
Survivin contributes to radiation resistance in head and neck cancer through regulation of DNA damage repair
Multi-omic profiling of gliomas reveals distinct DNA methylation changes at tumor recurrence
The importance of plasma cell biology in treating newly diagnosed multiple myeloma
Monday, April 18, 2016
Location
Section 11
Section 35
Section 33
Section 37
Section 20
Section 21
Section 5
Section 4
Section 34
Section 4
Section 17
Section 4
Section 9
Section 31
Section 15
Section 36
Time
Presentation # Poster # Author(s)
8:00am-12:00pm
LB-101
1 You-Take Oh
8:00am-12:00pm
1758
25 Caroline Um
8:00am-12:00pm
1701
28 Uma Krishnamurti
8:00am-12:00pm
1791
4 Veronika Fedirko
8:00am-12:00pm
1360
19 Omer Kucuk
8:00am-12:00pm
1388
19 Keerthi Gogineni
8:00am-12:00pm
1034
4 Gabriela Oprea-Ilies
8:00am-12:00pm
1008
8 Gabriela Oprea-Ilies
8:00am-12:00pm
2516
5 Daniel Brat
1:00pm-5:00pm
1866
4 Dongsheng Wang/Nabil Saba
1:00pm-5:00pm
2105
3 Puyu Shi
1:00pm-5:00pm
1892
30 MaKendra Umstead
1:00pm-5:00pm
2023
25 Birdal Bilir
1:00pm-5:00pm
2451
14 Abhinav Dey
1:00pm-5:00pm
2079
28 Lily Yang
1:00pm-5:00pm
2580
9 Lisa Flowers
Title (Click on presentation title for detail)
The expression of death receptor 4 is positively regulated by MEK/ERK signaling and suppressed upon MEK inhibition
Circulating insulin-like growth factors: Correlates and responses to calcium supplementation in colorectal adenoma patients
CCR6 associates with colon cancer metastasis
Effects of calcium and vitamin D supplementation on circulating markers of inflammation
Genistein-AR antagonist conjugate potently induce growth arrest in both androgen dependent and independent prostate cancer cell lines
Multi-template analysis in metastatic breast cancer blood samples
Leptin induces early onset and aggressiveness of pancreatic cancer
Leptin-induced NILCO in endometrial cancer is linked to obesity
TRIM8 modulates stem-like cells in glioblastoma
HER3 targeting sensitizes HNSCC to cetuximab - evidence from cell line and patient derived xenograft (PDX) models
c-Met hyperactivation is an universal resistance mechanism to both first and third generation EGFR inhibitors
Investigating the role of Aurora Kinase A as a positive regulator of MAPK signaling
SOX4 is essential for PTEN-mediated prostate tumorigenesis in vivo
Cancer stem cell survival postradiation in medulloblastomas requires YAP, YB1, and IGF2
IONP-LPrA2 and PEG-LPrA2 therapies for triple negative breast cancer
Optimizing cervical cancer screening for HIV-infected women: A risk-based approach
Location
Section 3
Section 24
Section 21
Section 6
Section 2
Section 21
Time
Presentation # Poster # Author(s)
8:00am-12:00pm
2757
15 Gou Chen
8:00am-12:00pm
3196
3 Laura Metrock
8:00am-12:00pm
3114
9 Omer Kucuk/Nabil Saba
1:00pm-5:00pm
3607
6 Debra Saxe
1:00pm-5:00pm
3502
12 Abu Anisuzzaman
1:00pm-5:00pm
3903
8 Mohammad Aminur Rahman
Section 14
Section 36
Section 37
Section 36
Section 29
1:00pm-5:00pm
1:00pm-5:00pm
1:00pm-5:00pm
1:00pm-5:00pm
1:00pm-5:00pm
You-Take Oh
Veronika Fedirko
Ashley Holmes
Roberd Bostick
David Rimland
Title (Click on presentation title for detail)
Mcl-1 dictates DNA double-strand break repair pathway choice
STAT3 inhibitor WP1066 as a novel therapeutic for medulloblastoma
Soy isoflavones modulate global methylation in head and neck squamous cell carcinoma (HNSCC)
An evaluation of NGS to identify gene fusions using RNA from FFPE solid tumor samples
Combination of BKM120 and erlotinib in squamous cell carcinoma of the head and neck: mechanism of in vitro and in vivo synergy
Optimizing the antitumor efficacy of AuNR-assisted plasmonic photothermal therapy and its molecular impact
B-Raf inhibition-induced paradoxical activation of MEK/ERK signaling enhances DR5 expression and DR5 activation-induced apoptosis in Ras-mutant
cancer cells
Mitochodrial D-loop polymorphisms are associated with colorectal adenoma risk
Associations of dietary inflammation scores with incident, sporadic adenoma
Mitochondrial DNA copy number, urinary isoprostanes and colorectal cancer risk
Multiplicative interaction between HIV infection status and FIB-4 in prediction of hepatocellular carcinoma risk
Tuesday, April 19, 2016
3725
4292
4319
4281
4308
18
12
10
1
28
Clinical Trials Plenary Session
Room 391, Morial Convention Center
10:30am-10:48am
CT096
Ragini Kudchadkar
Clinical activity, immune and viral correlates of PD-1 blockade with pembrolizumab as first systemic therapy in patients with advanced Merkel cell
carcinoma
Room 391, Morial Convention Center
11:44am-12:02pm
CT099
Nabil Saba
Nivolumab (nivo) vs investigator’s choice (IC) for recurrent or metastatic (R/M) head and neck squamous cell carcinoma (HNSCC): CheckMate-141
Alice Kamphorst
Rescue of exhausted CD8 T cells by PD-1 targeted therapies is CD28-dependent
Minisymposium
N.O. Theater C, Morial Convention Ctr. 3:30pm-5:30pm
4359
Invited Speaker
Room 283, Morial Convention Center
3:30pm-5:30pm
Suresh Ramalingam
New Drugs: A Review of Recent Breakthrough Therapies
Wednesday, April 20, 2016
Location
Section 11
Section 18
Section 11
Section 2
Time
Presentation # Poster # Author
7:30am-11:00am
LB-348
12 Melissa Gilbert-Ross
7:30am-11:00am
4770
21 Rui Jin
7:30am-11:00am
LB-355
19 Jessica Konen
7:30am-11:00am
4416
16 Ganji Purnachandra Nagaraju
Title (Click on presentation title for detail)
Developing a personalized anti-metastatic therapy to treat KRAS, LKB1-mutant lung adenocarcinoma
The regulation of pre-ribosomal RNA synthesis by LKB1
Image-guided genomics reveals a symbiotic relationship between heterogeneous phenotypes in collective cancer invasion
Combination of HSP90 and proteasome inhibitor is effective in pancreatic cancer
Section 20
7:30am-11:00am
Tolfenamic acid and curcumin treatment induces pancreatic cancer cell growth inhibition via suppressing Sp1 expression, NF-kB translocation to nucleus
4818
13 Bassel El-Rayes